Approval · Notice of Compliance 27276 · 2021
IXIFI: Notice of Compliance 27276
Issued December 21, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27276
- Date
- December 21, 2021
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IXIFI | 02523191 | Marketed |
Medicinal ingredients
- INFLIXIMAB 100 MG per VIAL